DEFINITIVE CONTRACT
Active75F40126C00060
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$688.1K
obligated · signed 2 weeks ago
TO CONDUCT AND DEFINE THE TECHNICAL AND PROGRAMMATIC REQUIREMENTS FOR A THREE-YEAR, MULTI-INSTITUTIONAL RESEARCH AND DEVELOPMENT EFFORT TO REVERSE ENGINEER, CHARACTERIZE, MANUFACTURE, AND EVALUATE PROTOTYPE LONG-ACTING POLY(LACTIC-CO-GLYCOLIC ACID)
Performance timeline
Start
Sep 30, 2026
Current end
Sep 29, 2028
Potential end
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
UNIVERSITY OF TEXAS AT AUSTIN
Contract 75F40126C00060
UEI
V6AFQPN18437
Parent Company
UNIVERSITY OF TEXAS SYSTEM
Capabilities & Certifications
Headquarters Location
Congressional District: 25
Current Obligation
$688,145
Base + Exercised Options
$688,145
Total Ceiling Value
$990,864
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.